Blood test kit
Snider , et al. October 25, 2
U.S. patent number D770,057 [Application Number D/503,093] was granted by the patent office on 2016-10-25 for blood test kit. This patent grant is currently assigned to Critical Care Diagnostics, Inc.. The grantee listed for this patent is Critical Care Diagnostics, Inc.. Invention is credited to David Geliebter, James V. Snider.
| United States Patent | D770,057 |
| Snider , et al. | October 25, 2016 |
Blood test kit
Claims
CLAIM The ornamental design for a blood test kit, as shown and described.
| Inventors: | Snider; James V. (San Diego, CA), Geliebter; David (Palm Beach Gardens, FL) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Applicant: |
|
||||||||||
| Assignee: | Critical Care Diagnostics, Inc.
(San Diego, CA) |
||||||||||
| Appl. No.: | D/503,093 | ||||||||||
| Filed: | September 23, 2014 |
Foreign Application Priority Data
| Apr 14, 2014 [EP] | 2447078-2 | |||
| Apr 14, 2014 [EP] | 2447078-3 | |||
| Current U.S. Class: | D24/223 |
| Current International Class: | 2402 |
| Field of Search: | ;D24/121,216,222-232 ;D10/78,81,103 ;422/408,430,501-504,68.1,547,67,411,401,420 ;436/163,164,169 ;435/6.16,91.1,6.11,287.1,287.2,7.1,7.9 ;600/300,583-584 ;356/440,445 |
References Cited [Referenced By]
U.S. Patent Documents
| 5728587 | March 1998 | Kang |
| 5939331 | August 1999 | Burd |
| 6239445 | May 2001 | Shaeef |
| 6267722 | July 2001 | Anderson |
| D454398 | March 2002 | Robertson |
| D456082 | April 2002 | Bouse |
| D467348 | December 2002 | McMichael |
| D468437 | January 2003 | McMenamy |
| D495805 | September 2004 | Lea |
| D500142 | December 2004 | Crisanti |
| 6855561 | February 2005 | Jerome |
| D512512 | December 2005 | Bell |
| D531321 | October 2006 | Godfrey |
| 7285425 | October 2007 | Shareef |
| D561344 | February 2008 | Kozak |
| 7326578 | February 2008 | Bateman |
| D602599 | October 2009 | Xiaowei |
| 7847946 | December 2010 | Krauth |
| D639977 | June 2011 | Francis |
| D640389 | June 2011 | Francis |
| D655424 | March 2012 | Castanon |
| D660977 | May 2012 | Wagner |
| D660978 | May 2012 | Wagner |
| 8268636 | September 2012 | Nazareth |
| D668350 | October 2012 | Rowley |
| D668779 | October 2012 | Khan |
| 8278109 | October 2012 | Nazareth |
| D676570 | February 2013 | Chance |
Other References
|
Sanada, et al.,"IL-33 and ST2 Comprise a Critical Biomechanically Induced and Cardioprotective Signaling System"; The Journal of Clinical Investigation; May 10, 2007. cited by applicant . Sanchez-Mas, et al.; "Modulcation of IL-33/ST2 System in Postinfraction Heart Failure: correlation with Cardiac Remodeling Markers"; European Journal of Clinical Investigation; vol. 44; 2014; pp. 643-651. cited by applicant . Seki, et al., "Interleukin-33 Prevents Apoptosis and Improves survival After Experimental Myocardial Infarction Through ST2 Signaling"; American Heart Association; Feb. 16, 2010. cited by applicant. |
Primary Examiner: Nelson; T. Chase
Assistant Examiner: Cavanna; Mark
Attorney, Agent or Firm: Fish & Richardson P.C.
Description
FIG. 1 is a front perspective view of a blood test kit showing the new design.
FIG. 2 is a top plan view thereof.
FIG. 3 is a bottom plan view thereof.
FIG. 4 is a left side view thereof.
FIG. 5 is a right side view thereof.
FIG. 6 is a front end side view thereof; and,
FIG. 7 is a back end side view thereof.
The features shown in broken lines in the drawings depict environmental subject matter only and form no part of the claimed design.
* * * * *
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 